其它抗肿瘤药

分享到：

点击具体产品，查看产品的最新价格，资讯，用途，供应信息

其它抗肿瘤药

资讯信息

其它抗肿瘤药

维罗非尼培美曲塞二钠保特佐米奥沙利铂康普瑞汀磷酸二钠来那度胺西地尼布卡铂顺铂米托坦3,8,13,18-Tetraazaeicosane-6,15-diol, hydrochloride (1:4), (6S,15S)-/艾鲁妥单抗戈莱恩尼单抗利妥昔单抗化合物 Flezurafenibum英夫利昔单抗Butanedioic acid, 1-[(1R,2S)-1-[[[(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl]oxy]carbonyl]-2-[[(1,1-dimethylethoxy)carbonyl]amino]-2-phenylethyl] ester锗螺胺OGX-011efineptakin alfaResearch Grade SoziniberceptAB521普马司他西他土珠3-[(4-氰基苯基)甲基]-N-(3-甲基-5-异噻唑基)-ALPHA-氧代-1-中氮茚乙酰胺化合物 T29964Samarium sm 153 lexidronam pentasodiumHu1D10(4-甲氧基苯基)(甲基)(2-甲基喹唑啉-4-基)胺BRICICLIB SODIUM8-氯腺苷-3',5'-环状磷酸钠盐LyMphoCideALDOXORUBICINCS-2398LisavanbulinTVB2640LIFIRAFENIBAstuprotimut-RBKT140化合物 T2584L2BMS-9862051822357-78-7化合物 T4532LMC-VC-PABC-AUR0101Muparfostat sodium(S)-4-(4'-氯联苯-4-基)-4-氧代-2-(苯硫基甲基)丁酸维汀-格仑妥木单抗RAD51-IN-2FARLETUZUMAB ( 法妥组单抗 )DROZITUMAB ( 曲齐妥单抗 )BrontictuzumabVandortuzumab VedotinZANIDATAMAB (泽尼达妥单抗 )CofetuzumabAMIVANTAMAB (埃万妥单抗 )AXATILIMAB (艾克利单抗 )TINENGOTINIB卡折来新莱莫尼利单抗培利霉素METHYL 5-AMINO-4-OXOPENTANOATEINTERFERON ALFA-N1辛曲秦利沃奇拜单抗艾瑞西普化合物 BOCODEPSINCobomarsensodiumOberotatug化合物 VerzistobartRosomidnarADOZELESINResearch Grade OnvapegleukinAlfaLEDOXANTRONE 盐酸盐1H-Isoindole-1,3(2H)-dione, 2-[(3S)-2,6-dioxo-3-piperidinyl]-4-[[[2-fluoro-4-[[3-(4-morpholinyl)-1-azetidinyl]methyl]phenyl]methyl]amino]-, hydrochloride (1:1)N-(Phosphonoacetyl)-L-aspartic acid 1,4-disodium saltTeroxironeDibenz[cd,g]indazol-6(2H)-one,5-[(3-aminopropyl)amino]-7,10-dihydroxy-2-[2-[(2-hydroxyethyl)amino]ethyl]-,hydrochloride (1:2)MGA271西达本胺1398568-47-21702967-37-0MOLIBRESIB BESYLATETAK-981Lorvotuzumab MertansineICRUCUMAB ( 艾芦库单抗 )FlanvotumabVorsetuzumab MafodotinLenzilumabTAFASITAMAB (ANTI-CD19)InebilizumabVadastuximabDepatuxizumab MafodotinBelantamabCETUXIMAB SAROTALOCAN (沙西妥昔单抗 )EPCORITAMAB (艾可瑞妥单抗 )Tavolimab比生群二盐酸盐MUTANT IDH1-IN-6帕武鲁他单抗莫帕利单抗TULMIMETOSTATEtoprine化合物 Osemitamab万多妥珠单抗Visugromab化合物 DL-01BECATECARINOlaptesedpegol化合物 PATRITUMAB DERUXTECAN德达博妥单抗米托洁林米托司培(6S,7S)-7-[(羟基氨基)甲酰基]-6-[(4-苯基-1-哌嗪基)甲酰基]-5-氮杂螺[2.5]辛烷-5-甲酸甲酯司韦芬Leurosine SulfateMITOCROMINUnii-W6E275iurxIPI-926CS-1107Cevipabulin fumarateSN2310PCI-24781 HCLLu-DOTA-TOC磷酸氢二钠(³²P)ElpamotideEDICOTINIB帕比司他乳酸水合物CadazolidLirilumabALG1001DS-3201Iberdomide hydrochlorideLUTETIUM LU177-DOTA-TATEPF 3084014 HYDROBROMIDE二水合氨甲嘌呤Tucotuzumab CelmoleukinONARTUZUMAB ( 奥那妥组单抗 )TarextumabLumretuzumabLilotomabAscrinvacumabCetrelimab奥博妥单抗TECLISTAMAB (特立妥单抗 )SERCLUTAMAB (思诺妥单抗 )PRALUZATAMAB (普罗妥单抗 )IMG-7289IMG-7289ONC-201 DIHYDROCHLORIDE, ONC-201 HCL, ONC201; ONC 201; ONC-201; NSC350625; NSC-350625; NSC 350625; IMIPRIDONE; TIC10; TIC 10; TIC-10化合物 T24466SECLIDEMSTAT MESYLATE埃纳妥单抗Gold-198L-Tyrosine, N-acetylglycyl-L-valyl-L-arginyl-L-alanyl-L-lysyl-L-alanylglycyl-L-valyl-L-arginyl-L-asparaginyl-L-norleucyl-L-phenylalanyl-L-lysyl-L-seryl-L-α-glutamyl-L-seryl-阿考达唑氯苯氨啶BA301BMS-986351, BMS986351, CC-95251, CC95251N-(2,6-bis(isopropyl)phenyl)-N'-((1-(4-(dimethylaminomethyl)phenyl)cyclopentyl)methyl)urea化合物 HDM-201 SUCCINATE枸橼酸沃拉西德尼半水合物化合物 INUPADENANT HCLL-Argininamide, N2-(4-fluorobenzoyl)-L-arginyl-L-arginyl-3-(2-naphthalenyl)-L-alanyl-L-cysteinyl-L-tyrosyl-N5-(aminocarbonyl)-L-ornithyl-L-lysyl-D-lysyl-L-prolyl-L-tyrosyl-L-arginyl-N5-(aminocarbonyl)-L-ornithyl-L-cysteinyl-, cyclic (4→13)-disulfide, acetate (1:)Immunoglobulin G1, anti-(human B7 homolog 4 protein) (human monoclonal INT-016 γ1-chain), disulfide with human monoclonal INT-016 κ-chain, dimer, reduced, 214′′,214′′′,220,220′,226,226′,229,229′-octakis(thioether) with N-[31-(3-mercapto-2,5-dioxo-3-pyrrolidinyl)-1,29-dioxo-4,7,10,13,16,19,22,25-octaoxa-28-azahentriacont-1-yl]-L-valyl-N-[(9S)-9-ethyl-2,3,9,10,13,15-hexahydro-9-hydroxy-10,13-dioxo-1H,12H-benzo[de]pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-4-yl]-L-alaninamide (ACI)化合物 CARBETIMER阿地白介素Tusamitamab3-Piperidinemethanol, 3-amino-1-[4-[(6-amino-9H-purin-9-yl)methyl]-6-(2,5-difluoro-4-methoxyphenyl)-3-pyridinyl]-α-(difluoromethyl)-, (αS,3R)-, (2S,3S)-2,3-dihydroxybutanedioate (1:1)Kw-2871替莱妥米单抗SARIDEGIB HYDROCHLORIDE甲磺酸艾日布林化合物 TIGAPOTIDE TRIFLUTATE5-Pyrimidinecarboxamide, 2-[(1a,5a,6a)-6-[[(6-fluoro-2-quinolinyl)methyl]amino]-3-azabicyclo[3.1.0]hex-3-yl]-N-hydroxy-LXS-196AdegramotideSamalizumabCC220PidilizumabG1T38戈利昔替尼化合物 LIFIRAFENIB MALEATETNF信号通路激活剂多肽FEXAPOTIDEMuparfostat化合物 T24610Oportuzumab MonatoxENSITUXIMAB ( 恩妥昔单抗 )TABALUMAB ( 他贝芦单抗 )Denintuzumab MafodotinVadastuximab TalirineVonlerolizumabTelisotuzumab VedotinFlotetuzumab伏派利单抗NAXITAMAB (那昔妥单抗 )MIRZOTAMAB (米佐妥单抗 )PACMILIMAB (帕克米利单抗 )RMC-4630贝伐珠单抗舒兰德林化合物 JSH-009拉格芙利单抗米帕妥单抗匹维奇单抗β-Alanine, N-(aminoiminomethyl)-, butanedioate (2:1)赛必妥单抗塞奥罗奈依沙芦星化合物NEDOMETINIB赛帕利单抗Benzamide, 5-fluoro-2-[[4-[7-[[(1S,3S,4R)-5-methylene-2-azabicyclo[2.2.2]oct-3-yl]carbonyl]-2,7-diazaspiro[3.5]non-2-yl]-5-pyrimidinyl]oxy]-N,N-bis(1-methylethyl)-, (2R,3R)-2,3-dihydroxybutanedioate (1:1)Efizonerimod alfaL-Valine, S-L-valyl-(3S,4E)-3-hydroxy-7-mercapto-4-heptenonyl-2-(aminomethyl)-4-thiazolecarbonyl-2-methylalanyl-, (5→2)-lactone, benzenesulfonate (1:1)Tilsotolimod sodiumPraluzatamab ravtansine戈替苏拜单抗Ozuriftamab vedotin (anti-ROR2)Research Grade OberotatugEciskafuspTagraxofuspZamzetoclax (compound 1)司沃妥塔单抗Antibiotic U-12,241catumaxomab得尼考新Anti-CD40L(SP-4-2)-[(7S,8S,17R,18R)-13-乙酰基-18-乙基-5-(2-甲氧基-2-氧代乙基)-2,8,12,17-四甲基-3-[[(2-磺酰乙基)氨基]甲酰基]-21H,23H-卟吩-7-丙酸(4-)-KN21,KN22,KN23,KN24]钯(2-)(-)-N-[4-(2,2-二甲基丙酰基)-5-[[2-(乙基氨基)乙磺酰胺]甲基]-5-苯基-4,5-二氢-1,3,4-噻二唑-2-基]-2,2-二甲基丙酰胺AVE8062AGlycine, L-γ-glutaMyl-S-(diMethylarsino)-L-cysteinyl-6-oxo-6,7,8,9,10,11-hexahydrocyclohepta[c][1]benzopyran-3-yl sulfaMateBEXLOSTERIDE.LEE011纳武单抗946150-57-8AMCASERTIBStrontium chloride sr 89 [USAN](223)RaCl21422253-38-0221139-79-3(2-hydroxyethyl)trimethylazanium: 3-methyl-1,1- dioxo-2H-l6-,2,4-benzothiadiazin-2-ideSULFO-PDBA-DM4Cevipabulin succinate//ASN-002_HydrochlorideCC-92480重组肿瘤坏死因子阿麦妥单抗RILOTUMUMAB ( 利妥木单抗 )UBLITUXIMAB ( 乌妥昔单抗 )NarnatumabDemcizumabImgatuzumabIstiratumabCarotuximabTOMARALIMAB (托拉利单抗 )Spiro[5,7-etheno-1H,11H-cyclobut[i][1,4]oxazepino[3,4-f][1,2,7]thiadiazacyclohexadecine-2(3H),1'(2'H)-naphthalen]-8(9H)-one, 6'-chloro-3',4',12,13,16,16a,17,18,18a,19-decahydro-16-methoxy-11,12-dimethyl-16-[[(9aR)-octahydro-2H-pyrido[1,2-a]pyrazin-2-yl]methyl]-, 10,10-dioxide, (1'S,11R,12S,14E,16R,1...沙戈匹隆塔拉妥单抗乌巴妥单抗L-Alaninamide, N-[10,10-dioxido-1,12-dioxo-14-[(1α,8α,9β)-bicyclo[6.1.0]non-4-yn-9-yl]-3,6,13-trioxa-10-thia-9,11-diazatetradec-1-yl]-L-valyl-N-[4-[[[[(11S,11aS)-8-[[5-[[(11aS)-5,11a-dihydro-7-methoxy-2-methyl-5-oxo-1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl]oxy]pentyl]oxy]-11,11a-dihydro-11-hydroxy-7-methoxy-2-methyl-5-oxo-1H-pyrrolo[2,1-c][1,4]benzodiazepin-10(5H)-yl]carbonyl]oxy]methyl]phenyl]-OZURIFTAMAB地宁妥珠单抗VobramitamabBOSEROLIMAB化合物 Enzomenib利托那韦EP杂质352-(1-环己基-4-哌啶基)-6-氟-2,3-二氢-3-氧代-1H-异吲哚-4-甲酰胺Research Grade Evorpacept2-133-Interleukin 2 [125-serine] (human), [65-[N6-[[2-[8-[4-[(2-hydroxyethyl)amino]-1,4-dioxobutyl]-8,9-dihydro-1H(or 3H)-dibenzo[b,f]-1,2,3-triazolo[4,5-d]azocin-1(or 3)-yl]ethoxy]carbonyl]lysine]] ether with α-hydro-ω-methoxypoly(oxy-1,2-ethanediyl) (ACI)Research Grade Nezastomig4-(Iodo-131I)-L-phenylalanineIBRITUMOMAB TIUXETANRevumenib柠檬酸盐1-Pyrrolidinecarboxamide, 3,3-dimethyl-N-[6-methyl-5-[[2-(1-methyl-1H-pyrazol-4-yl)-4-pyridinyl]oxy]-2-pyridinyl]-2-oxo-, hydrochloride, hydrate (1:1:1)Cintredekin besudotoxBenzamide, N-ethyl-5-fluoro-2-[[5-[2-[(1R)-4-[(2-methoxyethyl)methylamino]-1-(1-methylethyl)butyl]-2,6-diazaspiro[3.4]oct-6-yl]-1,2,4-triazin-6-yl]oxy]-N-(1-methylethyl)-, compd. with benzenesulfonate (1:2)溴匹立明阿柏西普N-(4-甲氧基苯基)-N,2-二甲基-4-喹唑啉胺盐酸盐瑞格非尼(水合物)TG-1013485-氨基乙酰丙酸NMDA脱氢雌马酚亚美克松MOCETINOSTAT HYDROBROMIDE 无结构图恩西地平TALAZOPARIB TOSYLATEEntolimod

其它抗肿瘤药

资讯信息

其它抗肿瘤药

最新供应信息